|
EPS8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.21319995663549E-09 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.481990E-01 |
| Stage1-vs-Stage3 |
1.108990E-01 |
| Stage1-vs-Stage4 |
7.126400E-01 |
| Stage2-vs-Stage3 |
6.882800E-01 |
| Stage2-vs-Stage4 |
3.166800E-01 |
| Stage3-vs-Stage4 |
3.798000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.58980000053432E-07 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
8.381800E-01 |
| Caucasian-vs-Asian |
1.558840E-01 |
| AfricanAmerican-vs-Asian |
4.573800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
2.364400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
6.582900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.322800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.496700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.892300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.878100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.038400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.714600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.355900E-02 |
| Classical-VS-Follicular |
6.13579997921221E-09 |
| Classical-VS-Other |
9.611500E-02 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
1.519280E-03 |
| Tall-VS-Other |
1.434990E-01 |
| Tall-VS-Normal |
1.62858615482264E-12 |
| Follicular-VS-Other |
8.047200E-01 |
| Follicular-VS-Normal |
1.65256697215455E-12 |
| Other-VS-Normal |
1.448360E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
4.101800E-01 |
|
|
